| Basics |
Ascendis Pharma A/S
Ascendis Pharma A/S is a biotechnology company that applies its TransCon technology to develop a pipeline of prodrug therapies with profiles that address markets with unmet medical needs.
|
| IPO Date: |
July 11, 2008 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$12.55B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$1.76 | 1.92%
|
| Avg Daily Range (30 D): |
$3.72 | 1.83%
|
| Avg Daily Range (90 D): |
$3.25 | 1.64%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.15M |
| Avg Daily Volume (30 D): |
.45M |
| Avg Daily Volume (90 D): |
.42M |
| Trade Size |
| Avg Trade Size (Sh.): |
66 |
| Avg Trade Size (Sh.) (30 D): |
47 |
| Avg Trade Size (Sh.) (90 D): |
47 |
| Institutional Trades |
| Total Inst.Trades: |
3,847 |
| Avg Inst. Trade: |
$3.56M |
| Avg Inst. Trade (30 D): |
$6.46M |
| Avg Inst. Trade (90 D): |
$6.24M |
| Avg Inst. Trade Volume: |
.03M |
| Avg Inst. Trades (Per Day): |
2 |
| Market Closing Trades |
| Avg Closing Trade: |
$3.37M |
| Avg Closing Trade (30 D): |
$7.04M |
| Avg Closing Trade (90 D): |
$6.69M |
| Avg Closing Volume: |
25.06K |
|
|
|
|
|
